Carl Zeiss Meditec AG (AFX.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In EUR
Address
Göschwitzer Straße 51-52
Jena, TH 07745
Germany
Phone
49 3641 2200
Sector
Healthcare
Industry
Medical - Specialties
Employees
5784
First IPO Date
March 22, 2000
| Name | Title | Pay | Year Born |
| Andreas Pecher | Interim Chairman of the Management Board & Interim CEO | 0 | 1971 |
| Christian Munster | Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board | 41,000 | 1971 |
| Justus Felix Wehmer | Chief Financial Officer & Member of the Management Board | 661,000 | 1965 |
| Eva-Maria Heine | Chief Human Resources Officer | 0 | N/A |
| Magnus Reibenspiess | Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology | 0 | N/A |
| Steven C. Schallhorn | Chief Medical Officer for Global Ophthalmic Devices | 0 | N/A |
| Euan S. Thomson | President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit | 0 | 1963 |
| Andrew Chang | Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc. | 0 | N/A |
| Sebastian Frericks | Director of Investor Relations | 0 | N/A |
| Stefanie Spanagel | Chief Operating Officer | 0 | N/A |
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.